Alveolus Bio
Harnessing the power of the live biotherapeutics and small molecules for the prevention and treatment of lung diseases
9 employees · est. 2020 · Boston, United States
Avalyn Pharma
Revolutionizing respiratory care with every breath
58 employees · est. 2011 · Boston, United States
Avalyn Pharma is the older company (2020 vs 2011); Avalyn Pharma is the larger of the two.
Side-by-Side Comparison
| Metric | Alveolus Bio | Avalyn Pharma |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2011 older |
| Headquarters | ||
| Headquarters | Boston, United States | Boston, United States |
| Employees | ||
| Employees | 9 | 58 larger |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Grant | Series C |
| Total Funding | ||
| Total Funding | $7.00M | $272.50M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Not tracked yet | Development of inhaled therapies, Drug delivery solutions, Clinical trials |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with rare lung diseases, Healthcare providers, Biopharmaceutical investors |
| Taxonomy | ||
| Taxonomy | Biotherapeutics, Lung Diseases, Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), Non-Cystic Fibrosis Bronchiectasis (NCFBE), Preclinical Stage, Inhaled Delivery, FDA-approved Therapeutics, Small Molecules, Live Biotherapeutics, Distal Lung Targeting, Drug Development, Innovation, Medical Research, Efficacy | Pulmonary Fibrosis Treatment, Respiratory Care, Inhaled Formulations, Interstitial Lung Diseases, Pirfenidone, Nintedanib, Idiopathic Pulmonary Fibrosis, Biopharma Company, Therapeutics Development, Lung Exposure, Systemic Exposure Reduction, Phase 2b MIST Study, Optimized Inhaled Therapies, Severe Respiratory Diseases, Drug Formulation |
| Website | ||
| Website | alveolusbio.com | avalynpharma.com |
About Alveolus Bio
Alveolus Bio is a biotechnology startup, founded in 2020, with a mission to harness the power of live biotherapeutics and small molecules for the prevention and treatment of lung diseases. The company's pipeline includes preclinical stage live biotherapeutics for Idiopathic Pulmonary Fibrosis (IPF),...
About Avalyn Pharma
Avalyn Pharma, founded in 2011 and headquartered in the United States, is pioneering advancements in the treatment of pulmonary fibrosis. With the slogan, “Revolutionizing respiratory care with every breath,” Avalyn is focused on creating innovative inhaled therapies. The company is reshaping respi...
We will tell you when either one moves
BounceWatch watches Alveolus Bio and Avalyn Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alveolus Bio and Avalyn Pharma — by email.
Frequently Asked Questions
Compare Alveolus Bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Alveolus Bio on 11 Sep 2024, and Avalyn Pharma on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.